Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri R Varadhachary

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Plos One|May 13, 2016
Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival OutcomesKanwal Raghav, Hemendra Mhadgut, Jennifer L McQuade, et al.
The Oncologist|February 1, 2021
Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic PortraitRyan W Huey, Brandon G Smaglo, Jeannelyn S Estrella, et al.
Abdominal Imaging|April 24, 2015
Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer stagingLeonardo P Marcal, Patricia S Fox, Douglas B Evans, et al.
Investigational New Drugs|September 30, 2005
Phase I trial of oral talactoferrin alfa in refractory solid tumorsTeresa G Hayes, Gerald F Falchook, Gauri R Varadhachary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of VaterMichael J Overman, Gauri R Varadhachary, Scott Kopetz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvisPatrick Kelly, Prajnan Das, Gauri R Varadhachary, et al.
Annals of Surgical Oncology|September 12, 2012
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvementDaniel E Abbott, Ryan P Merkow, Scott B Cantor, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Human Pathology|April 22, 2014
Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinomaRongjun Guo, Michael Overman, Deyali Chatterjee, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Plos One|May 13, 2016
Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival OutcomesKanwal Raghav, Hemendra Mhadgut, Jennifer L McQuade, et al.
The Oncologist|February 1, 2021
Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic PortraitRyan W Huey, Brandon G Smaglo, Jeannelyn S Estrella, et al.
Abdominal Imaging|April 24, 2015
Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer stagingLeonardo P Marcal, Patricia S Fox, Douglas B Evans, et al.
Investigational New Drugs|September 30, 2005
Phase I trial of oral talactoferrin alfa in refractory solid tumorsTeresa G Hayes, Gerald F Falchook, Gauri R Varadhachary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of VaterMichael J Overman, Gauri R Varadhachary, Scott Kopetz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvisPatrick Kelly, Prajnan Das, Gauri R Varadhachary, et al.
Annals of Surgical Oncology|September 12, 2012
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvementDaniel E Abbott, Ryan P Merkow, Scott B Cantor, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Human Pathology|April 22, 2014
Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinomaRongjun Guo, Michael Overman, Deyali Chatterjee, et al.
Pageof 12